Differentiation-inducing factor-1 suppresses gene expression of cyclin D1 in tumor cells

Tania Yasmin1, Fumi Takahashi-Yanaga, Jun Mori

  • 1Department of Clinical Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Insights

Differentiation-inducing factor-1 (DIF-1) inhibits tumor cell proliferation by reducing cyclin D1 expression. This occurs through the Wnt/beta-catenin signaling pathway, involving glycogen synthase kinase-3beta (GSK-3beta) activation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor cell proliferation is a hallmark of cancer.
  • Understanding the molecular mechanisms regulating cell proliferation is crucial for developing targeted therapies.
  • The Wnt/beta-catenin signaling pathway plays a significant role in cell growth and cancer development.

Purpose of the Study:

  • To elucidate the mechanism by which differentiation-inducing factor-1 (DIF-1) inhibits tumor cell proliferation.
  • To investigate the effect of DIF-1 on cyclin D1 gene expression and its regulatory pathways.

Main Methods:

  • Examined the effect of DIF-1 on cyclin D1 mRNA expression in HeLa and squamous cell carcinoma cells.
  • Assessed beta-catenin levels following DIF-1 treatment.
  • Investigated the role of glycogen synthase kinase-3beta (GSK-3beta) in DIF-1-mediated effects.
  • Utilized T-cell factor (TCF)/lymphoid enhancer factor (LEF) reporter plasmids and a human cyclin D1 promoter-driven reporter gene assay.

Main Results:

  • DIF-1 significantly reduced cyclin D1 mRNA expression and beta-catenin levels in cancer cells.
  • DIF-1 activated GSK-3beta, and GSK-3beta inhibition attenuated DIF-1-induced beta-catenin degradation.
  • DIF-1 suppressed TCF/LEF reporter activity and activity of a reporter gene driven by the human cyclin D1 promoter.
  • Deletion of the TCF/LEF consensus site in the cyclin D1 promoter abolished the effect of DIF-1.

Conclusions:

  • DIF-1 inhibits tumor cell proliferation by suppressing Wnt/beta-catenin signaling.
  • The mechanism involves GSK-3beta activation leading to beta-catenin degradation and reduced cyclin D1 promoter activity.
  • DIF-1 represents a potential therapeutic agent targeting aberrant Wnt/beta-catenin signaling in cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...